UT Health Science Center researchers reduce head and neck cancer in mice by 50 percent
September 6, 2016
A multidisciplinary research team at the UT Health Science Center San Antonio has found a new way to treat deadly, late-stage head and neck cancer, reducing tumor size in mouse models by 50 percent in just 14 days. The researchers found that targeting both the epidermal growth factor receptor and anaplastic lymphoma kinase pathways caused the tumors to shrink. They are seeking funding for clinical trials in humans.
